Free previewYou're reading the free part of this topic. The rest is included with Clinical.See what's included
Xerophthalmia
Cornea
1. Clinical Analogy & Conceptual Framework
The Analogy: "Drying Out a Fountain Pen"
Exam pearl
- Imagine your conjunctiva and cornea as a fountain pen that needs ink (mucin from goblet cells) to write smoothly. Vitamin A is the ink factory. When Vitamin A runs out, the goblet cells disappear - the pen runs dry. Initially the writing is scratchy (dry eye, Bitot's spots), then the nib corrodes irreversibly (corneal ulceration), and finally the entire pen is destroyed (keratomalacia, perforation, phthisis). The tragedy: unlike replacing ink, once the corneal "nib" melts, no amount of Vitamin A can restore vision - it is a race against time.
Conceptual Understanding
- Xerophthalmia (Greek: xeros = dry, ophthalmos = eye) is the spectrum of ocular manifestations resulting from Vitamin A Deficiency (VAD).
- Vitamin A Deficiency (VAD) is the leading preventable cause of childhood blindness worldwide and xerophthalmia is a clinical indicator of Vitamin A Deficiency (VAD).
- The disease is preventable and treatable in early stages, yet can lead to catastrophic irreversible blindness if corneal ulceration or keratomalacia is not promptly treated.
| Concept | Detail |
|---|---|
| Full name | • Xerophthalmia - clinical spectrum of ocular manifestations of vitamin A deficiency |
| Leading cause | • Vitamin A deficiency is a leading preventable cause of childhood blindness globally (World Health Organization) • The statement is understood in the context of affected populations and settings |
| Key molecule | • Retinol (Vitamin A1) - fat-soluble vitamin |
| Primary tissue effect | • Squamous metaplasia of mucus-secreting epithelia • Associated epithelial keratinization and loss of conjunctival goblet cells |
| Potentially reversible stages | • Night blindness (XN) • Conjunctival xerosis (X1A) • Bitot's spots (X1B) • Corneal xerosis (X2) |
| Severe, potentially irreversible stages | • Corneal ulceration or keratomalacia involving less than one-third of the corneal surface (X3A) • Corneal ulceration or keratomalacia involving one-third or more of the corneal surface (X3B) |
| Concept | Detail |
|---|---|
| Full name | • Xerophthalmia - clinical spectrum of ocular manifestations of vitamin A deficiency |
| Leading cause | • Vitamin A deficiency is a leading preventable cause of childhood blindness globally (World Health Organization) • The statement is understood in the context of affected populations and settings |
| Key molecule | • Retinol (Vitamin A1) - fat-soluble vitamin |
| Primary tissue effect | • Squamous metaplasia of mucus-secreting epithelia • Associated epithelial keratinization and loss of conjunctival goblet cells |
| Potentially reversible stages | • Night blindness (XN) • Conjunctival xerosis (X1A) • Bitot's spots (X1B) • Corneal xerosis (X2) |
| Severe, potentially irreversible stages | • Corneal ulceration or keratomalacia involving less than one-third of the corneal surface (X3A) • Corneal ulceration or keratomalacia involving one-third or more of the corneal surface (X3B) |
2. Epidemiology & Global Burden
Global Statistics
| Parameter | Data |
|---|---|
| Global vitamin A deficiency (VAD) - children | • About one in three children aged 6–59 months had vitamin A deficiency in 2013 • World Health Organization estimate |
| Clinical xerophthalmia | • ~4–5 million children/year |
| Corneal blindness from vitamin A deficiency (VAD) | • ~250,000–500,000 children/year |
| Mortality associated with vitamin A deficiency (VAD) | • In 2013, an estimated 94,500 diarrhoea deaths among children were attributable to vitamin A deficiency in low- and middle-income countries • In 2013, an estimated 11,200 measles deaths among children were attributable to vitamin A deficiency in low- and middle-income countries |
| Endemic regions | • South/South-East Asia • Sub-Saharan Africa • West Africa |
| Country burden | • Varies by metric, survey year, and local programme coverage • Report a dated source and metric rather than a fixed list of “highest burden countries” |
| India-specific | • A national nutrition-survey analysis estimated vitamin A deficiency at 17.5% after excluding children with elevated C-reactive protein • Vitamin A deficiency was defined as serum retinol <20 µg/dL |
| Age group most affected | • 6 months–6 years |
| Gender predisposition | • Male predominance has been reported in some populations • A growth-velocity explanation is not established |
| Seasonal variation | • Peaks in pre-harvest season (lean season) |
| Parameter | Data |
|---|---|
| Global vitamin A deficiency (VAD) - children | • About one in three children aged 6–59 months had vitamin A deficiency in 2013 • World Health Organization estimate |
| Clinical xerophthalmia | • ~4–5 million children/year |
| Corneal blindness from vitamin A deficiency (VAD) | • ~250,000–500,000 children/year |
| Mortality associated with vitamin A deficiency (VAD) | • In 2013, an estimated 94,500 diarrhoea deaths among children were attributable to vitamin A deficiency in low- and middle-income countries • In 2013, an estimated 11,200 measles deaths among children were attributable to vitamin A deficiency in low- and middle-income countries |
| Endemic regions | • South/South-East Asia • Sub-Saharan Africa • West Africa |
| Country burden | • Varies by metric, survey year, and local programme coverage • Report a dated source and metric rather than a fixed list of “highest burden countries” |
| India-specific | • A national nutrition-survey analysis estimated vitamin A deficiency at 17.5% after excluding children with elevated C-reactive protein • Vitamin A deficiency was defined as serum retinol <20 µg/dL |
| Age group most affected | • 6 months–6 years |
| Gender predisposition | • Male predominance has been reported in some populations • A growth-velocity explanation is not established |
| Seasonal variation | • Peaks in pre-harvest season (lean season) |
Risk Factors for Vitamin A Deficiency (VAD) - Exam High-Yield
- Dietary: Low intake of animal products (liver, eggs, dairy), green leafy vegetables, orange/yellow fruits
- Malabsorption: Chronic diarrhea, celiac disease, Crohn's, cystic fibrosis, intestinal surgery
- Increased demand: Rapid growth (infancy/childhood) and lactation can increase risk when intake is inadequate; pregnancy may increase requirements, but risk depends on baseline status and intake
- Infections: Measles can precipitate acute vitamin A deficiency and lower circulating vitamin A levels; diarrhoea can exacerbate vitamin A deficiency, while vitamin A deficiency increases the risk of respiratory and diarrhoeal infections
- Prematurity: Low hepatic stores at birth
- Exclusive breastfeeding beyond 6 months without complementary feeding from a mother with vitamin A deficiency: After 6 months, failure to introduce adequate complementary foods may increase risk, particularly when maternal vitamin A status is poor and breast-milk vitamin A is low; breastfeeding remains recommended
- Socioeconomic: Poverty, food insecurity, displacement
Free preview ends here
Keep reading Xerophthalmia
17 more sections are included with the Clinical plan.
- Vitamin A - Biochemistry & Ocular Physiology
- WHO Classification of Xerophthalmia
- Pathophysiology - Mechanism-Based Analysis
- Clinical Features - Stage-By-Stage Breakdown
- Bitot's Spots - Deep Dive
- Corneal Xerophthalmia & Keratomalacia